An Open-Label Single-Dose And Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oxymorphone Hydrochloride (HCl) For Acute Moderate To Severe Postoperative Pain In Pediatric Subjects
Phase: PHASE3
Conditions: Post-Operative Pain, Acute Pain
Sponsor: Endo Pharmaceuticals

This study was initiated at the request of the FDA as a class required Post-marketing Study in 
Pediatric Patients.